Production Of GlaxoSmithKline Plc's Ziagen HIV Oral Liquid Medicine

Palavras-chave

Bottles of Ziagen, an HIV oral liquid medication, move down the... Fotografia de notíciasAs Américas,Canadá,Cuidados de Saúde e Medicina,Doutor,EUA,Empacotar,Finanças,Garrafa,HIV,Horizontal,Líquido,Mississauga,Ontário - Canadá,Remédio,SIDA,Sede Principal,Toronto,Usar a BocaPhotographer Collection: Bloomberg 2010 BloombergBottles of Ziagen, an HIV oral liquid medication, move down the packaging line at the GlaxoSmithKline Canada Inc. headquarters in Mississauga, Ontario, Canada, on Monday, Dec. 13, 2010. Global sales of existing HIV medicines will peak at $12 billion in 2012, then halve by 2019 as patent expiries increase competition from generic drugs, according to a report by Datamonitor Group earlier this year. Photographer: Norm Betts/Bloomberg via Getty Images